Concept visual: Wild Bite Club.
An acid-active protease platform is probing whether dairy drinks and protein water can deliver more accessible amino acids without simply becoming heavier, thicker products.
Where It Could Go
If the approach survives formulation and human validation, protein beverages could split into two propositions: products that maximise protein quantity and products that optimise access to a moderate dose. A clear water format might serve light hydration or between-meal occasions, while a dairy base could offer a familiar breakfast or recovery experience. The enzyme could also become an ingredient platform sold to beverage manufacturers rather than a single branded drink.
The most interesting commercial route would pair a specific protein matrix with a tuned enzyme dose and evidence for that exact combination. That would move the category beyond generic digestive-enzyme decoration. It could also support reformulation goals: using less protein to reach a comparable amino-acid response, improving the nutritional performance of plant proteins, or extracting more value from lower-cost streams. All of those outcomes remain conditional until beverage prototypes and human data exist.
What Is Changing
Protein beverages have spent years competing on declared grams, flavour and format. A more consequential experiment asks whether a drink can create more nutritional value from the protein it already contains. The proposed lever is an acid-active protease: an enzyme that starts hydrolysing proteins in the stomach, releasing smaller peptides and amino acids earlier in digestion.
Amplifye is developing this approach around its P24 enzyme platform. Its current commercial expression is a capsule, while the company describes broader uses for proprietary proteases across food proteins. A recent US trademark application under the name DETENT extends the commercial signal into dairy-based drinks, milk-based drinks, protein-enriched water and powders for making protein water. The application is an early IP indicator, not evidence that any beverage has been formulated or launched. What is changing is therefore the design brief: instead of asking only how many grams fit in a bottle, developers may also ask how effectively those grams are broken down and made accessible.
How It Works
The technical logic begins with proteolysis. Proteases cut peptide bonds. The S53 family used in P24 is active at low pH, so it is intended to complement normal gastric digestion before intestinal enzymes finish the job. In a 2024 Frontiers in Nutrition paper, researchers affiliated with Digestiva—the earlier company name associated with the platform—and UC Davis tested S53 proteases using the standardised INFOGEST 2.0 in-vitro digestion model. Across soy, pea, chickpea, rice, casein and whey, the best-performing protease increased the degree of hydrolysis during the simulated gastric and intestinal phases. The authors explicitly state that human replication is needed, so the results support plausibility rather than a finished claim.
That gap is now being tested operationally. ClinicalTrials.gov lists a recruiting randomised, double-blind, placebo-controlled crossover study sponsored by Amplifye. Thirty healthy adults aged 45 to 75 are scheduled to eat a standardised mixed-protein burger meal with P24 or placebo; researchers will measure circulating amino acids, peptide profiles, hormones, glucose and subjective responses over three hours. It tests a capsule with a meal, not an enzyme formulated into a drink, and no results are posted.
A beverage adds a separate layer of formulation risk. Developers would have to control enzyme activity during processing and shelf life, prevent premature hydrolysis from creating bitterness or haze, preserve protein solubility, and show that heat, pH and packaging do not deactivate the enzyme. Clear protein water poses different challenges from milk-based drinks. The mechanism is credible; the product engineering remains open.
Why It Matters
Protein drinks often communicate through simple arithmetic: more grams implies more value. That measure is easy to compare, but it does not capture differences in digestibility, amino-acid composition, food matrix or processing. For consultants, enzyme-enhanced digestion could create a second competitive axis without forcing every brand into ever thicker, costlier, higher-protein formulations.
The opportunity is clearest where consumers have limited appetite, dislike heavy shakes or want protein during hydration rather than as a meal-sized product. Older adults and people eating less while using GLP-1 medicines are obvious research contexts, but they also raise the evidentiary bar: a useful beverage would need to demonstrate benefit rather than borrow a halo from the mechanism. UC Davis describes the platform as university-derived technology designed to work in the stomach’s acidic environment, while independent AgFunderNews reporting notes that broader health claims still require human validation. The transferable question is not merely whether an enzyme can be added. It is whether a stable, palatable drink can deliver a repeatable biological effect that consumers understand and regulators will permit a brand to explain.
What to Watch
Strong confirmation would begin with a named beverage prototype, ingredient statement and pilot-production evidence. Stability work should show that the protease remains active after processing and storage without creating bitterness, sediment or unwanted changes in clarity and texture. The current human study’s amino-acid results will matter, but a beverage-specific trial would be more relevant than a capsule taken with a mixed meal.
Also watch for a disclosed protein source, enzyme dose, manufacturing partner and claims strategy. Comparative data should separate declared protein, degree of hydrolysis, circulating amino acids and consumer outcomes rather than collapsing them into a single promise. For clear protein water, visual stability and flavour will be especially revealing; for dairy, heat treatment and shelf life are likely to be harder tests. A credible route to market will require all three systems—biochemistry, beverage engineering and communication—to align.
The WBC Read
This is a credible and unusually transferable experiment because it combines a defined biochemical mechanism, peer-reviewed in-vitro work and an active human study. It is commercially plausible as an ingredient strategy, especially in categories where increasing grams creates sensory or cost penalties. Yet the strongest evidence still concerns digestion models and a capsule taken with food, not a shelf-stable drink. The decisive uncertainty is formulation: activity, taste, clarity and claim substantiation must survive real processing. WBC would watch the human amino-acid data and the first beverage-specific stability work before treating protein efficiency as a new category platform rather than a promising ingredient story.